Frazier Life Sciences Management, L.P. Valneva Se Transaction History
Frazier Life Sciences Management, L.P.
- $2.36 Billion
- Q3 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Valneva Se stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 2,291,666 shares of VALN stock, worth $20.7 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
2,291,666
Previous 1,458,333
57.14%
Holding current value
$20.7 Million
Previous $8.27 Million
238.15%
% of portfolio
1.18%
Previous 0.44%
Shares
2 transactions
Others Institutions Holding VALN
# of Institutions
20Shares Held
5.27MCall Options Held
0Put Options Held
0-
Novo Holdings Hellerup, G72.35MShares$21.2 Million2.32% of portfolio
-
General American Investors CO Inc354KShares$3.21 Million0.26% of portfolio
-
Wells Fargo & Company San Francisco, CA154KShares$1.39 Million0.0% of portfolio
-
Morgan Stanley New York, NY33KShares$298,5320.0% of portfolio
-
Marshall Wace, LLP London, X031.2KShares$282,4590.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $625M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...